Cerebral malaria and immunogenetics

Parasite Immunology

Volumn 22, Issue 12, 2000, Pages 613-623

  Mazier, Dominique ^a   Nitcheu, Josiane ^a   Idrissa Boubou, Mariama ^a  

^a INSERM   (France)

Author keywords

Adhesion molecules; Candidate gene; Cerebral malaria; Cytokines; Plasmodium falciparum; Polymorphism

Indexed keywords

CELL ADHESION MOLECULE; COMPLEMENT RECEPTOR; HLA ANTIGEN CLASS 1; INTERLEUKIN 1; MANNOSE BINDING PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA;

BLOOD VESSEL OCCLUSION; BRAIN MALARIA; CONFERENCE PAPER; ENDOTHELIUM CELL; ERYTHROCYTE; GENETIC POLYMORPHISM; HUMAN; IMMUNOGENETICS; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

PLASMODIUM FALCIPARUM;

EID: 0033666150     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2000.00342.x     Document Type: Conference Paper

References (109)

1. Protection afforded by sickle-cell trait against subtertian malarial infection
2. The immunogenetics of resistance to malaria
3. Malaria and red cell genetic defects
4. Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36 thrombospondin, and intercellular adhesion molecule 1
5. Thrombospondin binds falciparum malaria parasitized erythrocytes may mediate cytoadherence
6. A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum infected erythrocytes
7. Monoclonal antibody OKM5 inhibits the in vitro binding of Plasmodium falciparum infected erythrocytes to monocytes endothelial and C32 melanoma cells
8. Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro
9. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum
10. Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: Roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1
11. PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes
12. Characterization of Plasmodium falciparum-infected erythrocyte and P-selectin interaction under flow conditions
13. 3 on human microvascular endothelial cells
14. Plasmodium falciparum-infected erythrocytes: A mutational analysis of cytoadherence via murine thrombomodulin
15. Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes
16. Plasmodium falciparum: Cytoadherence of malaria-infected erythrocytes to human brain capillary and umbilical vein endothelial cells: A comparative study of adhesive ligands
17. Differential binding of clonal variants of Plasmodium falciparum to allelic forms of intracellular adhesion molecule 1 determined by flow adhesion assay
18. Selective expression of adhesion molecules on human brain microvascular endothelial cells
19. Molecular mechanisms of cytoadherence in Malaria
20. Nitric oxide attenuates adhesion molecule expression in human endothelial cells
21. Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecules-1, vascular adhesion molecule-1, E-selectin expression in vascular endothelial cells increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction
22. Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria
23. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein complement-receptor 1
24. Involvement of CD36 on erythrocytes as a rosetting receptor for Plasmodium falciparum-infected erythrocytes
25. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans
26. Common west African HLA antigens are associated with protection from severe malaria
27. Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation
28. Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3
29. Increased susceptibility of malaria-infected variant erythrocytes to the mononuclear phagocyte system
30. Surface antigen expression on Plasmodium falciparum-infected erythrocytes is modified in alpha- and beta-thalassemia
31. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria
32. Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand
33. Effect of pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria
34. Polyclonal antitumor necrosis factor-? Fab used as an ancillary treatment for severe malaria
35. Involvement of IFN-g receptor-mediated signalling in protection against Plasmodium berghei infection and its pathology
36. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria
37. Impact of the -308 TNF promoter polymorphism on the transcriptionnal regulation of the TNF gene: Relevance to desease
38. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation
39. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles
40. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria
41. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration
42. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya
43. Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population
44. The major human rhinovirus receptor is ICAM-1
45. +cell mediated pathology
46. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria
47. Inducible nitric oxide synthase polymorphism and fatal cerebral malaria
48. Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, desease severity in Tanzanian children with malaria
49. Nitric oxide in Tanzanian children with malaria: Inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression
50. Plasmodium berghei: Is nitric oxide involved in the pathogenesis of mouse cerebral malaria?
51. The development of murine cerebral malaria does not require nitric oxide production
52. Malaria antigen and cytokine-induced production of reactive nitrogen intermediates by murine macrophages: No relevance to the development of experimental cerebral malaria
53. Effects of age and parasitemia on nitric oxide production/leukocyte nitric oxide synthase type 2 expresion in asymptomatic, malaria-exposed children
54. Upregulation of reactive oxygen and nitrogen intermediates in Plasmodium berghei infected mice after rescue therapy with chloroquine or artemether
55. Plasmodium falciparum rosetting is associated with malaria severity in Kenya
56. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria
57. Low dosages of interleukin 1 protect mice against lethal cerebral malaria
58. Differential reactivity of brain microvascular endothelial cells to TNF reflects the genetic susceptibility to cerebral malaria
59. Tumor necrosis factor and severe malaria
60. Intracerebral hemorrhages and infarction induced by a murine leukemia virus is influenced by host determinants within endothelial cells
61. Association and cosegregation of stroke with impaired endothelium-dependent vasorelaxation in stroke prone, spontaneously hypertensive rats
62. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells
63. Hypoxia vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells
64. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma
65. Late treatment with anti-LFA-1 (CD11a) antibody prevents cerebral malaria in a mouse model
66. Late administration of monoclonal antibody to leukocyte function-antigen 1 abrogates incipient murine cerebral malaria
67. TNF-induced microvascular pathology: Active role for platelets and importance of the LFA-1/ICAM-1 interaction
68. Electron microscopy of the human brain in cerebral malaria, Southeast Asian J Trop Med Public Health
69. Platelet accumulation in brain microvessels in fatal paediatric cerebral malaria
70. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria
71. T cell response in malaria pathogenesis: Selective increase in T cells carrying the TCR V (beta) 8 during experimental cerebral malaria
72. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria
73. Expression of major histocompatibility complex antigens on mouse brain microvascular endothelial cells in relation to susceptibility to cerebral malaria
74. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon
75. Segregation analysis detects a major gene controlling blood infection levels in human malaria
76. Genetic control of blood infection levels in human malaria: Evidence for a complex genetic model
77. Linkage analysis of blood Plasmodium falciparum levels: Interest of the 5q31-q33 chromosome region
78. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes
79. Cytoadherence of Plasmodium falciparum-infected erytrocytes to human melanoma cell lines correlates with surface OKM5 antigen
80. Plasmodium falciparum: Soluble thrombospondin increases cytoadherence of parasitized erythrocytes to human microvascular endothelium under shear flow conditions
81. Sequestrin, a CD36 recognition protein on malaria infected erythrocytes identified by anti-idiotype antibodies
82. Plasmodium chabaudi antigen Pf105, Plasmodium falciparum antigen Pf155, and erythrocyte band 3 share coss-reactive epitopes
83. Plasmodium falciparum erythrocytes rosetting is mediated by promiscuous lectin-like interactions
84. Novel fibrillar structure confers adhesive property to malaria-infected erythrocytes
85. Identification of Plasmodium falciparum erythrocyte membrane protein (PfEMP-1) as the rosetting ligand of the malaria parasite P. falciparum
86. Activated human platelets express beta 2 integrin
87. Detection in human blood platelets of sialyl Lewis X gangliosides, potentiel ligands for CD62 and other selectins
88. PECAM-1 (CD31) cloning and regulation to adhesion molecules of the immunoglobulin gene superfamilly
89. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1
90. CD31/PECAM-1 is a ligand for alpha (v) beta 3 integrin involved in adhesion of leukocytes to endothelium
91. Activation-independent binding of human memory T cells to adhesion molecule ELAM-1
92. P-selectin glycoprotein ligand-1 mediteas rolling of human neutrophils on P-selectin
93. 1-integrin under flow conditions
94. Platelet endothelial cell adhesion molecule, PECAM-1, modulates cell migration
95. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo
96. PECAM- 1 is required for transendothelial migration of leukocytes
97. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18
98. Circulating tumour necrosis factor is not involved of cerebral malaria in Plasmodium berghei-infected C57BL mice
99. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections
100. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria
101. Pentoxifylline prevents murine cerebral malaria
102. Selective damage of hippocampal neurons in murine cerebral malaria prevented by pentoxifylline
103. Tumor necrosis factor production in falciparum malaria and its association with schizont rupture
104. Strain variation in tumor necrosis factor induction by parasites from children with acute falciparum malaria
105. Tumor necrosis factor and disease severity in children with falciparum malaria
106. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria
107. Involvement of cytokines in the histopathology of cerebral malaria
108. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children